5R01NS082413-10 |
2022 |
$535369 |
Circadian dysfunction and neurodegenerative disease |
5R01NS082413-09 |
2021 |
$593432 |
Circadian dysfunction and neurodegenerative disease |
5R01NS082413-08 |
2020 |
$590289 |
Circadian dysfunction and neurodegenerative disease |
5R01NS082413-07 |
2019 |
$602414 |
Circadian dysfunction and neurodegenerative disease |
2R01NS082413-06 |
2018 |
$640247 |
Circadian dysfunction and neurodegenerative disease |
5R01NS082413-05 |
2017 |
$284518 |
Circadian dysfunction and GSK3 in neurodegenerative disease |
4R01NS082413-04 |
2016 |
$289125 |
CIRCADIAN DYSFUNCTION AND GSK3 IN NEURODEGENERATIVE DISEASE |
3R01NS082413-04S1 |
2016 |
$100000 |
CIRCADIAN DYSFUNCTION AND GSK3 IN NEURODEGENERATIVE DISEASE |
5R01NS082413-03 |
2015 |
$292978 |
CIRCADIAN DYSFUNCTION AND GSK3 IN NEURODEGENERATIVE DISEASE |
5R01NS082413-02 |
2014 |
$294655 |
CIRCADIAN DYSFUNCTION AND GSK3 IN NEURODEGENERATIVE DISEASE |
1R01NS082413-01 |
2013 |
$331926 |
CIRCADIAN DYSFUNCTION AND GSK3 IN NEURODEGENERATIVE DISEASE |